E R Price1, J D Brooks, E J Watson, S B Brennan, E A Comen, E A Morris. 1. Department of Radiology and Biomedical Imaging, Division of Women's Imaging, University of California, San Francisco, 1600 Divisadero Street, Room C-250, San Francisco, California, 94115, USA, elissa.price@ucsf.edu.
Abstract
OBJECTIVE: The objective of this study was to evaluate the effect of bilateral salpingo-oophorectomy (BSO) on background parenchymal enhancement (BPE) and the amount of fibroglandular tissue (FGT) seen on breast MRI. METHODS: Retrospective review identified 21 BRCA mutation carriers who underwent breast MRI before and after elective BSO. After exclusion of patients placed on postoperative hormone replacement therapy, there were 18 eligible patients. Blinded to surgical status, three independent readers used categorical scales to rate BPE (minimal, mild, moderate, marked) and the amount of FGT (fatty, scattered, heterogeneously dense, dense) on pre- and post-BSO MRI examinations. The sign test was used to assess for changes in the categorical ratings of BPE and FGT. RESULTS: Significant proportions of women demonstrated decreases in BPE and in the amount of FGT following oophorectomy (P = 0.004 and 0.02, respectively.) BPE decreases were larger and seen earlier than FGT changes. There was no significant relationship between age/body mass index and changes in BPE and FGT. CONCLUSIONS: BPE and the amount of FGT seen on breast MRI are significantly decreased by oophorectomy; BPE decreases to a greater extent and earlier than FGT. KEY POINTS: • Background parenchymal enhancement significantly decreases at breast MRI following oophorectomy. • Fibroglandular tissue significantly decreases on breast MRI following oophorectomy. • Decrease in background parenchymal enhancement is greater than in fibroglandular tissue. • Decrease in background parenchymal enhancement occurs earlier than in fibroglandular tissue.
OBJECTIVE: The objective of this study was to evaluate the effect of bilateral salpingo-oophorectomy (BSO) on background parenchymal enhancement (BPE) and the amount of fibroglandular tissue (FGT) seen on breast MRI. METHODS: Retrospective review identified 21 BRCA mutation carriers who underwent breast MRI before and after elective BSO. After exclusion of patients placed on postoperative hormone replacement therapy, there were 18 eligible patients. Blinded to surgical status, three independent readers used categorical scales to rate BPE (minimal, mild, moderate, marked) and the amount of FGT (fatty, scattered, heterogeneously dense, dense) on pre- and post-BSO MRI examinations. The sign test was used to assess for changes in the categorical ratings of BPE and FGT. RESULTS: Significant proportions of women demonstrated decreases in BPE and in the amount of FGT following oophorectomy (P = 0.004 and 0.02, respectively.) BPE decreases were larger and seen earlier than FGT changes. There was no significant relationship between age/body mass index and changes in BPE and FGT. CONCLUSIONS: BPE and the amount of FGT seen on breast MRI are significantly decreased by oophorectomy; BPE decreases to a greater extent and earlier than FGT. KEY POINTS: • Background parenchymal enhancement significantly decreases at breast MRI following oophorectomy. • Fibroglandular tissue significantly decreases on breast MRI following oophorectomy. • Decrease in background parenchymal enhancement is greater than in fibroglandular tissue. • Decrease in background parenchymal enhancement occurs earlier than in fibroglandular tissue.
Authors: Valencia King; Yajia Gu; Jennifer B Kaplan; Jennifer D Brooks; Malcolm C Pike; Elizabeth A Morris Journal: Eur Radiol Date: 2012-07-04 Impact factor: 5.315
Authors: Valencia King; Shari B Goldfarb; Jennifer D Brooks; Janice S Sung; Benjamin F Nulsen; Jolanta E Jozefara; Malcolm C Pike; Maura N Dickler; Elizabeth A Morris Journal: Radiology Date: 2012-07-06 Impact factor: 11.105
Authors: S Ciatto; N Houssami; A Apruzzese; E Bassetti; B Brancato; F Carozzi; S Catarzi; M P Lamberini; G Marcelli; R Pellizzoni; B Pesce; G Risso; F Russo; A Scorsolini Journal: Breast Date: 2005-08 Impact factor: 4.380
Authors: Valencia King; Jennifer D Brooks; Jonine L Bernstein; Anne S Reiner; Malcolm C Pike; Elizabeth A Morris Journal: Radiology Date: 2011-04-14 Impact factor: 11.105
Authors: Ingrid E Fakkert; Marian J E Mourits; Liesbeth Jansen; Dorina M van der Kolk; Kees Meijer; Jan C Oosterwijk; Bert van der Vegt; Marcel J W Greuter; Geertruida H de Bock Journal: Cancer Prev Res (Phila) Date: 2012-09-25
Authors: Stefan O R Pfleiderer; Steffen Sachse; Dieter Sauner; Christiane Marx; Ansgar Malich; Susanne Wurdinger; Werner A Kaiser Journal: Breast Cancer Res Date: 2004-03-16 Impact factor: 6.466
Authors: Kathryn H Schmitz; Nancy I Williams; Despina Kontos; Susan Domchek; Knashawn H Morales; Wei-Ting Hwang; Lorita L Grant; Laura DiGiovanni; Domenick Salvatore; Desire' Fenderson; Mitchell Schnall; Mary Lou Galantino; Jill Stopfer; Mindy S Kurzer; Shandong Wu; Jessica Adelman; Justin C Brown; Jerene Good Journal: Breast Cancer Res Treat Date: 2015-10-28 Impact factor: 4.872
Authors: Alana A Lewin; Sungheon Gene Kim; James S Babb; Amy N Melsaether; Jason McKellop; Melanie Moccaldi; Ana Paula Klautau Leite; Linda Moy Journal: Acad Radiol Date: 2016-01-07 Impact factor: 3.173
Authors: Shandong Wu; Susan P Weinstein; Michael J DeLeo; Emily F Conant; Jinbo Chen; Susan M Domchek; Despina Kontos Journal: Breast Cancer Res Date: 2015-05-19 Impact factor: 6.466
Authors: Jennifer D Brooks; Janice S Sung; Malcolm C Pike; Irene Orlow; Frank Z Stanczyk; Jonine L Bernstein; Elizabeth A Morris Journal: Int J Cancer Date: 2018-03-25 Impact factor: 7.396
Authors: Jennifer D Brooks; Rebecca A G Christensen; Janice S Sung; Malcolm C Pike; Irene Orlow; Jonine L Bernstein; Elizabeth A Morris Journal: NPJ Breast Cancer Date: 2022-08-25
Authors: Roxanna Hellgren; Ariel Saracco; Fredrik Strand; Mikael Eriksson; Ann Sundbom; Per Hall; Paul W Dickman Journal: Acta Radiol Date: 2020-03-26 Impact factor: 1.990